Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Aichi, 470-1192, Japan.
F1000Res. 2020 Apr 23;9:285. doi: 10.12688/f1000research.23458.2. eCollection 2020.
SARS-CoV-2 is the coronavirus agent of the COVID-19 pandemic causing high mortalities. In contrast, the widely spread human coronaviruses OC43, HKU1, 229E, and NL63 tend to cause only mild symptoms. The present study shows, by analysis, that these common human viruses are expected to induce immune memory against SARS-CoV-2 by sharing protein fragments (antigen epitopes) for presentation to the immune system by MHC class I. A list of such epitopes is provided. The number of these epitopes and the prevalence of the common coronaviruses suggest that a large part of the world population has some degree of specific immunity against SARS-CoV-2 already, even without having been infected by that virus. For inducing protection, booster vaccinations enhancing existing immunity are less demanding than primary vaccinations against new antigens. Therefore, for the discussion on vaccination strategies against COVID-19, the available immune memory against related viruses should be part of the consideration.
SARS-CoV-2 是导致 COVID-19 大流行的冠状病毒病原体,死亡率很高。相比之下,广泛传播的人类冠状病毒 OC43、HKU1、229E 和 NL63 往往只会引起轻微症状。本研究通过分析表明,这些常见的人类病毒通过共享可被 MHC Ⅰ类呈递给免疫系统的蛋白片段(抗原表位),有望诱导针对 SARS-CoV-2 的免疫记忆。本文提供了这样的表位列表。这些表位的数量和常见冠状病毒的流行率表明,即使没有感染过该病毒,世界上很大一部分人口已经对 SARS-CoV-2 具有一定程度的特异性免疫力。为了诱导保护,增强现有免疫的加强针接种比针对新抗原的初级疫苗接种要求更低。因此,在讨论针对 COVID-19 的疫苗接种策略时,应考虑针对相关病毒的现有免疫记忆。